BKNG

On the business itself, Booking is a high-quality compounder. Revenue has more than doubled in four years ($11.0B FY2021 → $17.1B → $21.4B → $23.7B → $26.9B FY2025), with FY2025 up 13.4% YoY, and the model is exceptionally asset-light: operating income of $8.82B (+16.8%, a 32.8% operating margin) on just $322M of capex (down 24.9%). Operating cash flow of $9.41B (+13.0%) against that tiny capex implies roughly $9.1B of free cash flow, which management is funneling straight back to holders — $6.44B of buybacks plus $1.25B of dividends in FY2025, shrinking the share count 3.5%. The balance sheet carries $17.2B of cash against $18.8B of total debt ($16.9B long-term + $1.88B current), so net leverage is modest relative to a near-$9B annual FCF engine.

A word of caution on the valuation lens: the provided inputs do not reconcile. Price of $171.78 against diluted EPS of $165.57 yields a P/E of ~1.0 and a P/S of 0.2 — implausible for a business of this quality — and the $165.57 EPS does not square with the $2.55B net income figure (itself tagged FY2015, i.e. stale/mislabeled) and 31.7M shares. I therefore treat the headline 'cheapness' as unreliable rather than as a thesis pillar. The negative stockholders' equity of -$5.58B (and the resulting -45.7% ROE) is NOT distress — it is the arithmetic of years of aggressive buybacks against $40.7B of retained earnings, a well-understood feature of capital-return-heavy compounders, not insolvency given the cash and cash generation.